Depression and Anxiety Trial, Recruiting NCT06574035 Sponsor: University of Michigan Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06574035
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men who identify as African American or Black
  • Adults aged 18 years or older
  • People who are able to walk and move around independently
  • People who have been diagnosed with Type 2 Diabetes for at least one year
  • People who are currently under a doctor's care for their diabetes and who report having an A1C blood sugar level of 7.0% or higher in the past year
  • People who are willing to take part in weekly physical activity sessions, exercise sessions, CBT (talk-based) sessions, group discussions, and in-person health check-ups
  • People who have a reliable internet connection or unlimited mobile data to complete study tasks on a tablet, phone, or computer
  • People who live in Wayne or Washtenaw County
  • People who have reliable transport to attend in-person events

Who may not be able to join:

  • People with stage 2 high blood pressure (as defined by a specific medical guideline called JNC VIII) (confirm with trial site)
  • People who have had a recent heart attack or other cardiac event
  • People who have recently had laser eye surgery for a diabetes-related eye condition
  • People who have had a stroke
  • People who have had a lower leg or foot amputation
  • People with nerve damage in the feet or legs (peripheral neuropathy)
  • People with severe lung disease requiring oxygen at rest
  • People with serious heart failure (classified as Class III or IV)
  • People whose health is currently considered medically unstable
  • People currently experiencing ongoing chest pain at rest or unstable angina
  • People with an uncontrolled irregular heartbeat that is affecting blood circulation
  • People with an active heart lining infection (endocarditis)
  • People with a severe narrowing of the heart's aortic valve that is causing symptoms
  • People with current inflammation of the heart muscle or the sac around the heart
  • People with a sudden tear in the body's main artery (aortic dissection)
  • People with a recent blood clot in the lungs (pulmonary embolism or pulmonary infarction)
  • People with a blood clot in a deep vein
  • People with a physical condition that would make exercise testing unsafe
  • People currently experiencing chest discomfort during physical activity, unusual shortness of breath, dizziness, fainting, or blackouts
  • People who are currently receiving talk therapy (psychotherapy) from a mental health provider specifically for the treatment of depression — though people who are only receiving medication management from a psychiatrist for depression may still be considered eligible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 January 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in A1C; Change in General Quality of Life (12-Item Short Form Survey (SF-12)); Change in Diabetes-Related Distress (The Type 2 Diabetes Distress Assessment System); Change in Diabetes Quality of Life (Diabetes Quality of Life Instrument)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov